{"entity":{"type":"insider","cik":"0001612094","url":"/insider/0001612094","json_url":"/insider/0001612094.json","name":"Clark Mitchall G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":13,"first":"2015-08-19","last":"2018-05-21","span_basis":"filed_date"},"name_variants":[{"name":"Clark Mitchall G.","source":"filing","n_filings":13,"first_seen":"2015-08-19","last_seen":"2018-05-21"}],"transactions":[{"id":6454620,"accession":"0001209191-18-032073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-032073","line_url":"/filing/0001209191-18-032073#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25860.0,"shares_display":"25,860","price_per_share":50.03,"price_display":"50.03","price_state":"stated","total_value":1293775.8,"total_display":"1,293,775.80","total_whole":"1,293,776","shares_owned_after":107972.0,"shares_owned_after_display":"107,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-21","scope":"insider"},{"id":6421828,"accession":"0001209191-18-030724","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-030724","line_url":"/filing/0001209191-18-030724","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4647.0,"shares_display":"4,647","price_per_share":46.05678502259522,"price_display":"46.06","price_state":"stated","total_value":214025.88,"total_display":"214,025.88","total_whole":"214,026","shares_owned_after":134132.0,"shares_owned_after_display":"134,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-16","scope":"insider","n_lines":2},{"id":6705410,"accession":"0001209191-18-022904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-022904","line_url":"/filing/0001209191-18-022904#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22400.0,"shares_display":"22,400","price_per_share":40.07,"price_display":"40.07","price_state":"stated","total_value":897568.0,"total_display":"897,568.00","total_whole":"897,568","shares_owned_after":133671.0,"shares_owned_after_display":"133,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-29","filed_date":"2018-04-03","scope":"insider"},{"id":6145978,"accession":"0001209191-18-021991","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-18-021991","line_url":"/filing/0001209191-18-021991","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100203.0,"shares_display":"100,203","price_per_share":37.87373451892658,"price_display":"37.87","price_state":"stated","total_value":3795061.82,"total_display":"3,795,061.82","total_whole":"3,795,062","shares_owned_after":202124.0,"shares_owned_after_display":"202,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-27","filed_date":"2018-03-28","scope":"insider","n_lines":6},{"id":4662006,"accession":"0001209191-17-061606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-061606","line_url":"/filing/0001209191-17-061606#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3290.0,"shares_display":"3,290","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":46718.0,"total_display":"46,718.00","total_whole":"46,718","shares_owned_after":163052.0,"shares_owned_after_display":"163,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-17","scope":"insider"},{"id":5120814,"accession":"0001209191-17-049447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-049447","line_url":"/filing/0001209191-17-049447#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3021.0,"shares_display":"3,021","price_per_share":14.33,"price_display":"14.33","price_state":"stated","total_value":43290.93,"total_display":"43,290.93","total_whole":"43,291","shares_owned_after":159130.0,"shares_owned_after_display":"159,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-17","scope":"insider"},{"id":4415725,"accession":"0001209191-17-033189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-033189","line_url":"/filing/0001209191-17-033189#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3873.0,"shares_display":"3,873","price_per_share":15.25,"price_display":"15.25","price_state":"stated","total_value":59063.25,"total_display":"59,063.25","total_whole":"59,063","shares_owned_after":153000.0,"shares_owned_after_display":"153,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-17","scope":"insider"},{"id":4103157,"accession":"0001209191-17-011765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-011765","line_url":"/filing/0001209191-17-011765#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (EVP & Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3059.0,"shares_display":"3,059","price_per_share":15.96,"price_display":"15.96","price_state":"stated","total_value":48821.64,"total_display":"48,821.64","total_whole":"48,822","shares_owned_after":149661.0,"shares_owned_after_display":"149,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-16","scope":"insider"},{"id":2110609,"accession":"0001209191-16-150862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-150862","line_url":"/filing/0001209191-16-150862#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2995.0,"shares_display":"2,995","price_per_share":19.53,"price_display":"19.53","price_state":"stated","total_value":58492.35,"total_display":"58,492.35","total_whole":"58,492","shares_owned_after":95187.0,"shares_owned_after_display":"95,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-17","scope":"insider"},{"id":3127455,"accession":"0001209191-16-121432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-121432","line_url":"/filing/0001209191-16-121432#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4153.0,"shares_display":"4,153","price_per_share":15.15,"price_display":"15.15","price_state":"stated","total_value":62917.95,"total_display":"62,917.95","total_whole":"62,918","shares_owned_after":83759.0,"shares_owned_after_display":"83,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"},{"id":2052547,"accession":"0001209191-16-100246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-100246","line_url":"/filing/0001209191-16-100246#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4153.0,"shares_display":"4,153","price_per_share":15.35,"price_display":"15.35","price_state":"stated","total_value":63748.55,"total_display":"63,748.55","total_whole":"63,749","shares_owned_after":80700.0,"shares_owned_after_display":"80,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-16","filed_date":"2016-02-18","scope":"insider"},{"id":8849496,"accession":"0001209191-15-081087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-081087","line_url":"/filing/0001209191-15-081087#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4153.0,"shares_display":"4,153","price_per_share":31.67,"price_display":"31.67","price_state":"stated","total_value":131525.51,"total_display":"131,525.51","total_whole":"131,526","shares_owned_after":34785.0,"shares_owned_after_display":"34,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-16","filed_date":"2015-11-18","scope":"insider"},{"id":8675852,"accession":"0001209191-15-067016","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-067016","line_url":"/filing/0001209191-15-067016#line-4","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612094","owner_name":"Clark Mitchall G.","owner_display_name":"Clark Mitchall G.","owner_url":"/insider/0001612094","role":"Officer (Chief R & QA Officer)","role_mark":"O","role_mark_label":"Officer (Chief R & QA Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief R & QA Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7829.0,"shares_display":"7,829","price_per_share":46.19,"price_display":"46.19","price_state":"stated","total_value":361621.51,"total_display":"361,621.51","total_whole":"361,622","shares_owned_after":34130.0,"shares_owned_after_display":"34,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (EVP & Chief R & QA Officer)","n_filings":13,"first_seen":"2015-08-19","last_seen":"2018-05-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612094","retrieved_at":"2026-08-23T06:17:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}